University of Pittsburgh

Wei Du Lab


The laboratory of Dr. Wei Du integrates multi-disciplinary approaches spanning molecular biology, DNA damage repair, stem cell biology, in vivo model, to study the underlying mechanisms regulating normal and abnormal hematopoiesis, with a special focus on the pathophysiology of hematologic diseases such as bone marrow (BM) failure and leukemia. For our latest news: LinkedIn.


The ASCI is an honorary society to which more than 2,800 physician-scientists from all medical specialties belong. Prospective members are proposed by standing members of the society and elected to ASCI on the basis of an outstanding record of scholarly achievement in biomedical research. The ASCI includes physician-scientists who are active clinically, in basic research, or in teaching. Many of its senior members are widely recognized leaders in academic medicine. As of 2015 the membership of ASCI has included 417 members of the National Academy of Medicine, 191 members of the National Academies of Sciences, Engineering, and Medicine, 40 Lasker Award winners, and 19 Nobel laureates. Dr. Du is a newly elected member for ASCI in 2026! Congratulations!!! here.

Read presse release from PITT School of Medicine here

.


Dr. Du co-chairs METABOLISM, STEM CELLS, AND CANCER session for 2025 ISSCR annual meeting. Read here.


Dr. Du received a new 5-year RF1 award to study DNA damage-induced immune response in ageing Read here. The Du lab at University of Pittsburgh is recruiting new postdocs. Applyhere


Dr. Du has received the prestigious Blood Cancer United, formerly Leukemia & Lymphoma Society (LLS) Scholar Award to expand her research program focusing on "DNA damage, immune response, aging and leukemia". Congratulations!!!


Dr. Du has received two new NIH grants to study Leukemia-Associated Macrophages and aging hematopoiesis. Congratulations!!! Read here.